Register Now • Awards Gala →
September 14th, 2016
Cambridge, MA-based C4 Therapeutics has named chief scientific officer Andrew Phillips its president. Phillips is taking over for former president and CEO Jason Fisherman, who has resigned to pursue other opportunities.
Ben Fidler is Xconomy's Deputy Biotechnology Editor. You can e-mail him at firstname.lastname@example.org Follow @benthefidler
Xconomy Insight · Special Report
Success or failure depends on you. Get advice from the experts to help your startup succeed
From Our Editors · Video
Video interview with David Berry, general partner at Flagship Pioneering.
Providence Ventures shares its advice on making successful invest
The Hidden Risks of Sourcing Human Biological Samples
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2018, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.